ClinicalTrials.gg
Sign In

Vision Disorders clinical trials

The registry lists 360 studies for Vision Disorders across more than 10 countries. 84 are recruiting or about to start. 129 of them are mainly about Vision Disorders (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06. Counting its 7 narrower conditions too, such as Amblyopia: 885 studies, 199 open.

Get an email when these change. Save the Vision Disorders studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
178
Recruiting
46
Status unknown
37
Not yet recruiting
32
Terminated
24
Active, not recruiting
19

Phase

Phase 3
48
Phase 2
28
Phase 4
17
Phase 1
16
Early Phase 1
2

Where

United States
111
France
42
United Kingdom
37
Canada
33
Germany
31
China
30

Who runs them

Novartis Pharmaceuticals (32) · National Eye Institute (NEI) (7) · Kodiak Sciences Inc (7) · Laboratoires Thea (7) · Johnson & Johnson Vision Care, Inc. (5) · Bayer (5) · National Taiwan University Hospital (5) · Johns Hopkins University (5)

What is being tested here

Drugs under test in Vision Disorders studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Sepofarsen134
Tributyrin101
Faricimab111
Fluocinolone Acetonide111
Phentolamine111
Valproic Acid101
Clemastine101
Cyclopentolate101
Tropicamide101
Ranibizumab01322

Drug classes tested here Angiogenesis inhibitors 1 open · Corticosteroids 1 open

Coming up

5phase 3 studies under way
22studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 46 Vision Disorders studies recruiting now, 21 (46%) set no upper age limit and 16 (35%) stop at 75 or younger. 18 (39%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 13 (28%) take healthy volunteers.

Recruiting studies that take each age, of 46
AgeWomenMen
1014 (30%)14 (30%)
1832 (70%)32 (70%)
3031 (67%)31 (67%)
4030 (65%)30 (65%)
5031 (67%)31 (67%)
6530 (65%)30 (65%)
7530 (65%)30 (65%)
8527 (59%)27 (59%)

Across all 360 studies, recruiting or not: 30% stop at 75 or younger and 26% at 65; 31% take children; 1% are for women only and <1% for men only; 33% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Vision Disorders studies take

Of 17 phase 3 interventional studies under Vision Disorders, half reached primary completion within 26 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 326 mo21–28 · 17 studies——
Interventional, no phase24 mo6–51 · 94 studies—31 mo7–51 · 84 studies
Observational23 mo12–52 · 58 studies—23 mo10–42 · 51 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 360. Browse all 360 → or search them.